6505--Contingency Medication Compounding Services

SOL #: 36C25626Q0332Combined Synopsis/Solicitation

Overview

Buyer

Veterans Affairs

Veterans Affairs, Department Of

256-NETWORK CONTRACT OFFICE 16 (36C256)

RIDGELAND, MS, 39157, United States

Place of Performance

Houston, TX

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Original Source

https://sam.gov/opp/8d92dfb67ce241d7ae0774a94abb9668/view

Timeline

Posted

Feb 6, 2026

Last Updated

Feb 11, 2026

Submission Deadline

Feb 16, 2026, 9:00 PM

Qualification Details

Fit reasons

NAICS alignment with historical contract wins in similar service areas.
Scope strongly matches core technical capabilities and delivery model.

Risks

Past performance thresholds may require one additional teaming partner.
Potential clarification needed on staffing minimums before bid/no-bid.

Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), specifically the Michael E. Debakey VA Medical Center in Houston, TX, is seeking Emergency Contingency Services for Hazardous and Non-Hazardous Medication Compounding. This is a combined synopsis/solicitation issued as an RFQ for commercial products and services. The contract will be a Firm-Fixed Price, Indefinite-Delivery-Indefinite-Quantity (IDIQ). Quotes are due by February 16, 2026, at 3:00 PM CST.

Scope of Work

The required services include the provision of hazardous and non-hazardous agents, IV tubing, closed system drug transfer devices, and other necessary items. Contractors will perform aseptic compounding of agents based on patient-specific orders. Timely transportation of compounded orders via courier or overnight mail is essential. All compounding, labeling, and dating must comply with USP 797, USP 800, and Federal Law. Offerors must also provide current and future certification reports for sterile compounding areas and hoods, and submit the "VHA PBM Assessment Guide for Compounded Sterile Preparations" at the time of response and annually.

Contract Details

Contract Type: Firm-Fixed Price, Indefinite-Delivery-Indefinite-Quantity (IDIQ)
Period of Performance: One year from the date of award
Set-Aside: Unrestricted
NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing) with a small business size standard of 1,300 employees
FSC/PSC: 6505 (Drugs And Biologicals)
Place of Performance: Michael E. Debakey VAMC, Building 100, Room 2A-290, 2002 Holcombe Blvd., Houston, TX 77030

Submission & Evaluation

This solicitation is issued as an RFQ, and a written solicitation document will not be issued. Quotes must be submitted electronically via email to Eugene.Jackson2@va.gov by 3:00 PM CST on February 16, 2026. The email subject line must be "RFQ 36C25626Q0332–Pharmacy Contingency Contract for Hazardous and Non-Hazardous Compounding." Evaluation will be based on the Lowest Price Technically Acceptable (LPTA) method, considering Technical factors (Brand Name or Equal, Contingency Plan) and Price. Offerors must complete annual representations and certifications via SAM.gov.